Brian O Mahony/X
Nov 4, 2025, 09:17
HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
Brian O Mahony, CEO of Irish Haemophilia Society, Former President of WFH and EHC, posted on X.
” The first of our HaemophiliaIRL series of 6 clinical webinars has just started.
This evenings topic: New Therapeutic Possibilities for von Willebrand Disease.
Speaker is Prof. David Lillicrap from Canada. All who registered will recieve a specific e -zine and link to recording.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM